VRNA - Verona Pharma plc

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
64.48M
Enterprise Value 3
55.95M
Trailing P/E
N/A
Forward P/E 1
-2.42
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
0.69
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 6
N/A

Trading Information

Stock Price History

Beta (3Y Monthly) -0.94
52-Week Change 3-61.13%
S&P500 52-Week Change 315.09%
52 Week High 312.5000
52 Week Low 33.6500
50-Day Moving Average 34.3248
200-Day Moving Average 34.8894

Share Statistics

Avg Vol (3 month) 34.03k
Avg Vol (10 day) 33.77k
Shares Outstanding 513.17M
Float 4.34M
% Held by Insiders 10.00%
% Held by Institutions 165.57%
Shares Short (Oct 31, 2019) 4579
Short Ratio (Oct 31, 2019) 40.13
Short % of Float (Oct 31, 2019) 4N/A
Short % of Shares Outstanding (Oct 31, 2019) 40.00%
Shares Short (prior month Sep 30, 2019) 4238

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in GBP.

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-39.10%
Return on Equity (ttm)-52.09%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)N/A
Diluted EPS (ttm)-2.3360
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)N/A
Total Cash Per Share (mrq)N/A
Total Debt (mrq)N/A
Total Debt/Equity (mrq)2.68
Current Ratio (mrq)4.07
Book Value Per Share (mrq)6.56

Cash Flow Statement

Operating Cash Flow (ttm)N/A
Levered Free Cash Flow (ttm)N/A